Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Cancer Biology
  • View Item
  • Home
  • ICR Divisions
  • Cancer Biology
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Alterations in the phosphoproteomic profile of cells expressing a non-functional form of the SHP2 phosphatase.

Thumbnail
Publication Date
2016-09
ICR Author
Huang, Paul
Iwai, Leo
Author
Corallino, S
Iwai, LK
Payne, LS
Huang, PH
Sacco, F
Cesareni, G
Castagnoli, L
Type
Journal Article
Metadata
Show full item record
Abstract
The phosphatase SHP-2 plays an essential role in growth factor signaling and mutations in its locus is the cause of congenital and acquired pathologies. Mutations of SHP-2 are known to affect the activation of the RAS pathway. Gain-of-function mutations cause the Noonan syndrome, the most common non-chromosomal congenital disorder. In order to obtain a holistic picture of the intricate regulatory mechanisms underlying SHP-2 physiology and pathology, we set out to characterize perturbations of the cell phosphorylation profile caused by an altered localization of SHP-2. To describe the proteins whose activity may be directly or indirectly modulated by SHP-2 activity, we identified tyrosine peptides that are differentially phosphorylated in wild type SHP-2 cells and isogenic cells expressing a non-functional SHP-2 variant that cannot dephosphorylate the physiological substrates due to a defect in cellular localization upon growth factor stimulation. By an iTRAQ based strategy coupled to mass spectrometry, we have identified 63 phosphorylated tyrosine residues in 53 different proteins whose phosphorylation is affected by SHP-2 activity. Some of these confirm already established regulatory mechanisms while many others suggest new possible signaling routes that may contribute to the modulation of the ERK and p38 pathways by SHP-2. Interestingly many new proteins that we found to be regulated by SHP-2 activity are implicated in the formation and regulation of focal adhesions.
URL
https://repository.icr.ac.uk/handle/internal/2096
Collections
  • Cancer Biology
  • Molecular Pathology
Version of record
10.1016/j.nbt.2015.08.002
Subject
NIH 3T3 Cells
Animals
Humans
Mice
Phosphotyrosine
Protein Array Analysis
Proteomics
Biotechnology
MAP Kinase Signaling System
Phosphorylation
Models, Biological
Mutant Proteins
Mass Spectrometry
Protein Tyrosine Phosphatase, Non-Receptor Type 11
HEK293 Cells
Research team
Protein Networks
Molecular and Systems Oncology
Language
eng
Date accepted
2015-08-14
License start date
2016-09
Citation
New biotechnology, 2016, 33 (5 Pt A), pp. 524 - 536

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.